Jump to content

List of pharmaceutical companies

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Bazaras (talk | contribs) at 07:20, 22 February 2010. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

The following is a list of the twelve largest pharmaceutical companies ranked by revenue as of July 2009 in the Fortune Global 500.[1]

Rank[1] Company Country Total Revenues (USD millions) Net income/ (loss) (USD millions) Employees
1 Johnson & Johnson United States 63,747.0[2] 12,949.0 118,700
2 Pfizer United States 48,296.0[3] 8,104.0 81,800
3 GlaxoSmithKline United Kingdom 44,654.0[4] 8,438.6 99,003
4 Roche Switzerland 44,267.5[5] 8,288.1 80,080
5 Sanofi-Aventis France 42,179.0[6] 5,636.7 98,213
6 Novartis Switzerland 41,459.0[7] 8,195.0 96,717
7 AstraZeneca United Kingdom 31,601.0[8] 6,101.0 65,000
8 Abbott Laboratories United States 29,527.6[9] 4,880.7 68,838
9 Merck United States 23,850.3[10] 7,808.4 55,200
10 Wyeth United States 22,833.9[11] 4,417.8 47,426
11 Bristol-Myers Squibb United States 21,366.0[12] 5,247.0 35,000
12 Eli Lilly United States 20,378.0[13] (2,071.9) 40,500

The following is a list of the 49 largest pharmaceutical and biotech companies ranked by healthcare revenue as of 2008.[14] Some companies (eg, Johnson and Johnson and Procter & Gamble) have additional revenue not included here.[citation needed]

}

Alphabetical listing

It is limited to those companies notable enough to have articles in Wikipedia.

1-A

B-D

E-L

M

N

O

P

R

S

T

U-Z

See also

References

  1. ^ a b "Fortune Global 500 2009 Pharmeceutical Industry". Fortune. 160 (2). 2009. Retrieved 2009-12-18. {{cite journal}}: Unknown parameter |month= ignored (help)
  2. ^ "Johnson & Johnson - JNJ". Fortune. 2009-07-20. Retrieved 2010-02-12.
  3. ^ "Pfizer - PFE". Fortune. 2009-07-20. Retrieved 2010-02-12.
  4. ^ "GlaxoSmithKline - GSK". Fortune. 2009-07-20. Retrieved 2010-02-12.
  5. ^ "Roche Group - RHHVF". Fortune. 2009-07-20. Retrieved 2010-02-12.
  6. ^ "Sanofi-Aventis - SNY". Fortune. 2009-07-20. Retrieved 2010-02-12.
  7. ^ "Novartis - NVS". Fortune. 2009-07-20. Retrieved 2010-02-12.
  8. ^ "AstraZeneca - AZN". Fortune. 2009-07-20. Retrieved 2010-02-12.
  9. ^ "Abbott Laboratories - ABT". Fortune. 2009-07-20. Retrieved 2010-02-12.
  10. ^ "Merck - MRK". Fortune. 2009-07-20. Retrieved 2010-02-12.
  11. ^ "Wyeth - WYE". Fortune. 2009-07-20. Retrieved 2010-02-12.
  12. ^ "Bristol-Myers Squibb - BMY". Fortune. 2009-07-20. Retrieved 2010-02-12.
  13. ^ "Eli Lilly - LLY". Fortune. 2009-07-20. Retrieved 2010-02-12.
  14. ^ a b "Global 500". 2008. Retrieved 2009-07-27.
  15. ^ "Pfizer Annual Report" (PDF). 2008. Retrieved 2009-07-24.
  16. ^ "Wyeth Annual Report" (PDF). 2008. Retrieved 2009-07-24.
  17. ^ "Kennzahlen Bayer Konzern". 2008. Retrieved 2009-07-27.
  18. ^ "Abbott Annual Report" (PDF). 2008. Retrieved 2009-07-24.
Rank[14] Company Country Total Revenues (USD millions) Healthcare R&D 2008 (USD millions) Net income/ (loss) 2008 (USD millions) Employees 2008
1 Pfizer[15] (with Wyeth[16]) U.S. 70,696 11,318 14,111 137,127
2 Johnson & Johnson U.S. 63,747 NA 10,576 119,200
3 Bayer [17] Germany 48,149 3,770 6,448 108,600
4 Hoffmann–La Roche Switzerland 43,970 NA 8,135 78,604
5 Novartis Switzerland 41,460 NA 11,946 98,200
6 GlaxoSmithKline United Kingdom 40,424 6,373 10,432 103,483
7 Sanofi-Aventis France 40,328 NA 7,204 99,495
8 AstraZeneca UK/Sweden 31,601 NA 5,959 67,400
9 Abbott Laboratories[18] U.S. 29,527 2,688 4,880 68,697
10 Merck & Co. U.S. 23,850 4,678 7,808 74,372
11 Bristol-Myers Squibb U.S. 19,977 NA 2,165 42,000
12 Eli Lilly and Company U.S. 18,634 NA 2,953 40,600
13 Boehringer Ingelheim Germany 16,959 1,977 2,163 43,000
14 Takeda Pharmaceutical Co. Japan 15,697 1,620 2,870 15,000
15 Amgen U.S. 14,771 3,366 3,166 48,000
16 Genentech U.S. 13,400 15773 3,640 33,500
17 Baxter International U.S. 12,300 614 1,397 38,428
18 Teva Pharmaceutical Industries Israel 11,080 495 546 26,670
19 Astellas Pharma Japan 10,701 1,435 1,122 23,613
20 Daiichi Sankyo Japan 9,682 1,459 671 20,100
21 Novo Nordisk Denmark 9,081 1,063 1,922 26,575
22 Procter & Gamble U.S. 8,964 NA 10,340 29,258
23 Eisai Japan 5,583 926 604 14,993
24 Merck KGaA Germany 5,175 772 1,258 13,900
25 Alcon U.S. 4,897 512 1,348 13,500
26 SINOPHARM China 4,700 498 1249 9700
27 Akzo Nobel Netherlands 4,694 741 1,449 13,000
28 UCB Belgium 4,426 1,024 492 12,741
29 Nycomed Switzerland 4,264 NA -105 10,533
30 Forest Laboratories U.S. 3,442 941 454 9,649
31 Solvay Belgium 3,268 533 1,026 9,000
32 Genzyme U.S. 3,187 650 -17 8,477
32 Allergan U.S. 3,063 1,056 -127 8,423
33 Gilead Sciences U.S. 3,026 384 -1,190 6,772
34 CSL Australia 2,788 161 454 6,400
35 Chugai Pharmaceutical Co. Japan 2,787 467 328 5,962
36 Biogen Idec U.S. 2,683 718 218 5,907
37 Bausch & Lomb U.S. 2,292 197 15 5,830
38 Taiho Pharmaceutical Co. Japan 2,069 244 132 5,756
39 King Pharmaceuticals U.S. 1,989 254 289 5,191
40 Watson Pharmaceuticals U.S. 1,979 131 -445 5,126
41 Mitsubishi Pharma Japan 1,945 403 208 5,111
42 Shire UK 1,797 387 278 4,958
43 Cephalon U.S. 1,764 403 145 4,913
44 Dainippon Sumitomo Pharma Japan 1,763 350 193 3,750
45 Kyowa Hakko Kogyo Japan 1,698 268 108 2,895
46 Shionogi Japan 1,640 320 159 2,868
47 Mylan Laboratories U.S. 1,612 104 217 2,800
48 H. Lundbeck Denmark 1,552 329 186 2,515
49 Abdi Ibrahim Ilac Turkey 850[1] 100 250 1,700